Clinical Trial

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU

Name: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU — clinical trial record (NCT07552012)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find out the efficacy and safety of oral FXS5626 in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).

Trial Details

NCT Number	NCT07552012
Lead Sponsor	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Conditions	Active Non-anterior, Non-infectious Uveitis
Enrollment	40 participants
Start Date	2026-01-29
Primary Completion	2027-02-28 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-27